Sensitivity and specificity of commercially available rapid diagnostic tests for viral hepatitis B and C screening in serum samples
- PMID: 32667957
- PMCID: PMC7363090
- DOI: 10.1371/journal.pone.0235036
Sensitivity and specificity of commercially available rapid diagnostic tests for viral hepatitis B and C screening in serum samples
Abstract
Early diagnosis of chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections is pivotal for optimal disease management. Sensitivity and specificity of 19 rapid diagnostic test (RDT) kits by different manufacturers (ABON, CTK Biotech, Cypress Diagnostics, Green Gross, Human Diagnostic, Humasis, InTec, OraSure, SD Bioline, Wondfo) were assessed on serum samples of 270 Mongolians (90 seropositive for hepatitis B surface antigen (HBsAg), 90 seropositive for hepatitis C antibody (HCV-Ab), 90 healthy subjects). All tested RDTs for detection of HBsAg performed with average sensitivities and specificities of 100% and 99%, respectively. Albeit, overall sensitivity and specificity of RDTs for detection of HCV-Ab was somewhat lower compared to that of HBsAg RDTs (average sensitivity 98.9%, average specificity 96.7%). Specificity of RDTs for detection of HCV-Ab was dramatically lower among HBsAg positive individuals, who were 10.2 times more likely to show false positive test results. The results of our prospective study demonstrate that inexpensive, easy to handle RDTs are a promising tool in effective HBV- and HCV-screening especially in resource-limited settings.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
-
- Global hepatitis report, 2017 [Internet]. 2017. Available from: https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/
-
- Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128. 10.1016/S0140-6736(12)61728-0 - DOI - PMC - PubMed
-
- Tang LSY, Covert E, Wilson E, Kottilil S. Chronic Hepatitis B infection a review. JAMA—J Am Med Assoc. 2018;319(17):1802–13. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources